Abstract
Background As the number of COVID-19 cases increased precipitously in the US, policymakers and health officials marshalled their pandemic responses. As the economic impacts multiplied, anecdotal reports noted the increased use of online crowdfunding to defray these costs. We examined the online crowdfunding response in the early stage of the COVID-19 pandemic in the US.
Methods On May 16, 2020, we extracted all available data available on US campaigns created between January 1 and May 10, 2020 on GoFundMe and identified the subset of COVID-related campaigns using keywords relevant to the COVID-19 pandemic. We explored incidence of COVID-related campaigns by geography, by category, and over time and compared campaign characteristics to non-COVID-related campaigns after March 11 when the pandemic was declared.
Results We found that there was a substantial increase in overall GoFundMe online crowdfunding campaigns in March, largely attributable to COVID-related campaigns. However, as the COVID-19 pandemic persisted and progressed, the number of campaigns per COVID-19 cases declined more than tenfold across all states. COVID-related campaigns raised more money, had a longer narrative description, and were more likely to be shared on Facebook than other campaigns in the study period.
Conclusions Online crowdfunding appears to be a transient stopgap, predicated on the novelty of an emergency rather than the true sustained need of a community. Rather, crowdfunding activity is likely an early marker for communities in acute distress that could be used by governments and aid organizations to guide disaster relief and policy.
Trial registration N/A
Competing Interest Statement
Dr. Lehmann reports stock ownership in Celanese Corporation and Colfax Corporation. There are no other competing interests.
Funding Statement
None.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The University of Texas Southwestern Human Research Protection Program Policies, Procedures, and Guidance did not require institutional review board approval as all data were publicly available.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data that support the findings of this study are available upon request.
